ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$NUVB:NYSE · Nuvation Bio Inc - US

Sector: health

Conviction from: Citrini

52-week range: 3.829.75

Nuvation Bio is a biopharmaceutical company developing therapies for oncology, addressing difficult-to-treat cancers.

3 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 66 — mean of 3 scored holder(s) · buyers (new/add) avg 61. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy267,032$1,495,3790.0%
David Einhorn / Greenlight45Holds (flat)34,995$195,9720.0%
Stanley Druckenmiller / Duquesne91Trimmed -50%2,269,900$12,7110.3%

Beyond 13F — activists, insiders, politicians & research

Citrini Research coverage report library →

ReportDateStance
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami2025-05-28LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.